A tool assists clinicians in evaluating the probability of a lung nodule being cancerous. This assessment combines patient characteristics, such as age and smoking history, with nodule features observed on imaging, including size, location, and shape. For instance, a model might input a 65-year-old former smoker with a 1 cm spiculated nodule in the upper lobe to estimate the likelihood of malignancy.
These instruments provide several advantages. They aid in shared decision-making between physicians and patients regarding the need for further diagnostic testing, such as biopsies or imaging surveillance. By quantifying risk, they can help reduce unnecessary invasive procedures. The development of these prediction models has evolved alongside advances in medical imaging and statistical methodologies, improving the accuracy and reliability of risk stratification in pulmonary medicine.